GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » Book Value per Share

Shanghai HeartCare Medical Technology (HKSE:06609) Book Value per Share : HK$30.30 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology Book Value per Share?

Shanghai HeartCare Medical Technology's book value per share for the quarter that ended in Dec. 2023 was HK$30.30.

During the past 12 months, Shanghai HeartCare Medical Technology's average Book Value Per Share Growth Rate was -9.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai HeartCare Medical Technology was 143.40% per year. The lowest was 13.40% per year. And the median was 78.40% per year.

Shanghai HeartCare Medical Technology's current price is HK$16.88. Its book value per share for the quarter that ended in Dec. 2023 was HK$30.30. Hence, today's PB Ratio of Shanghai HeartCare Medical Technology is 0.56.

During the past 5 years, the highest P/B Ratio of Shanghai HeartCare Medical Technology was 6.83. The lowest was 0.55. And the median was 0.84.

Good Sign:

Shanghai HeartCare Medical Technology Corp Ltd stock PB Ratio (=0.59) is close to 3-year low of 0.55


Shanghai HeartCare Medical Technology Book Value per Share Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology Book Value per Share Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
2.32 20.80 43.28 33.51 30.30

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only 43.28 39.10 33.51 31.48 30.30

Competitive Comparison of Shanghai HeartCare Medical Technology's Book Value per Share

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's PB Ratio falls into.



Shanghai HeartCare Medical Technology Book Value per Share Calculation

Shanghai HeartCare Medical Technology's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,176.5-0.0)/38.8
=30.30

Shanghai HeartCare Medical Technology's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,176.5-0.0)/38.8
=30.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Shanghai HeartCare Medical Technology  (HKSE:06609) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Shanghai HeartCare Medical Technology Book Value per Share Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.
Executives
Ding Kui 2201 Interest of corporation controlled by you
Wisary Limited 2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines